TSRI Scientists Zero in on Treatment for Charcot-Marie-Tooth Disease

News Scientists at The Scripps Research Institute (TSRI) have now shown a path to developing treatments for disease subtype CMT2D. As they report in the journal Nature Communications, it may be possible to reverse the disease by ... Contributed Author: Scripps Research Institute Topics: Regenerative Medicine